Fundraising FoxEiger BioPharmaceuticals
Santa Clara, US · 4 known investors
Find your way into Eiger BioPharmaceuticals
Sign up to find every way you can get introduced to Eiger BioPharmaceuticals
- Your email: who you already know at Eiger BioPharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eiger BioPharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
JG
Jeffrey GlennNamed on SEC filing
DC
David CoryNamed on SEC filing
Board
NK
EE
Ed EnglemanBoard director
Investors · 4
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
Also in the syndicate · 1
Vivo Ventureslead
Funding
SEC filings, press & company announcements$20.5M disclosed across 2 of 3 rounds · 2009–2015
- Undisclosed amountSeries AFeb 2009
InterWest Partners (lead), Vivo Ventures (lead)
Source ↗
▶$6MraisedNov 2015 · 4 investors · BiotechnologyRule 506(b)
▶$6MraisedNov 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas DietzDirector
- David CoryExecutive Officer, Director
- Nina KjellsonDirector
- Ed EnglemanDirector
- Jeffrey GlennDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.5MraisedMar 2015 · 8 investors · BiotechnologyRule 506(b)
▶$14.5MraisedMar 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nina KjellsonDirector
- Ed EnglemanDirector
- Jeffrey GlennDirector
- David CoryExecutive Officer, Director
- Offering amount
- $14.6M
- Amount sold
- $14.5M
- First sale
- Apr 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Eiger BioPharmaceuticals's investors?
- Eiger BioPharmaceuticals's investors include Pfizer Venture Investments, Canaan Partners, Vivo Capital.
- How much funding has Eiger BioPharmaceuticals raised?
- Eiger BioPharmaceuticals has disclosed $20.5M raised across 2 of its 3 known rounds.
- Where is Eiger BioPharmaceuticals headquartered?
- Eiger BioPharmaceuticals is headquartered in Santa Clara, US.